2m 2m 2m 2m 2m 2m 2m
REGENXBIO (RGNX)
NASDAQ
$6.70+$0.18 (+2.68%)
Price as of Jun 03, 2026 7:30 PM EDT- $362.4MMarket Cap
- -35.64%1-Year Change
- BiotechnologyIndustry
REGENXBIO (RGNX)
$6.70+$0.18 (+2.68%)
RGNX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.52 | ||
Change | -$0.62 (-8.68%) | ||
Open | $7.07 | ||
High | $7.09 | ||
Low | $6.44 | ||
Previous Close | $7.14 | ||
Volume | 1,642,017 | ||
30-Day Average Volume | 2,099,595 | ||
1-Week Change | 3.33% | ||
1-Month Change | -28.51% | ||
1-Year Change | -35.64% | ||
3-Year Change | -66.94% | ||
5-Year Change | -81.39% | ||
Fundamentals | |||
Shares Outstanding | 51.7M | ||
Total Assets | $341.9M | ||
Market Cap | $362.4M | ||
Enterprise Value | $347.2M | ||
Period: QTR TTM FY | |||
Revenue | $5.1M | ||
Net Income | -$90.1M | ||
Free Cash Flow | -$77.4M | ||
EBIT | $102.4M | ||
EBITDA | $106.3M | ||
Net Working Capital | $115.4M | ||
EPS | -$1.72 | ||
Enterprise Value/EBITDA | 3 | ||
Enterprise Value/Revenue | 68 | ||
P/B | 17 | ||
P/E | -4 | ||
PEG | 0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue